In particular, the mRNA down-regulation of Insr, Irs1 and Irs2, in association with reduced phosphorylation of Akt and reduced Glut4 expression, suggests that Zip7 activity may be amenable to manipulation as a novel approach for the treatment of insulin resistance in skeletal muscle. The gene discussed is IRS2; the disease is Insulin resistance.